NAION from Ozempic & Semaglutide
Ozempic contains semaglutide, which can help regulate blood sugar levels and increase insulin secretion. It’s approved to treat type 2 diabetes, but the medication’s impact on appetite and satiety has also made it widely used for weight loss.
However, recent studies have shown that semaglutide medications like Ozempic may increase the risk of non-arteritic anterior ischemic optic neuropathy (NAION), a condition that can cause sudden and permanent vision loss.
A Massachusetts Eye and Ear study found that:
- Patients with type 2 diabetes prescribed semaglutide were about 4 times more likely to develop NAION than those on other diabetes medications
- Patients who were overweight or obese and were prescribed semaglutide were over 7 times more likely to develop NAION than those on other weight-loss medications
Because the warning labels on these medications may not have mentioned the risk of NAION, anyone who developed vision loss or blindness after taking Ozempic may be able to pursue compensation from a NAION semaglutide lawsuit.
As a national personal injury law firm, Sokolove Law has helped thousands of clients hold the companies responsible for their injuries accountable. See if you may be eligible for compensation from an Ozempic NAION lawsuit.
Get the Help You Deserve
If you developed NAION after using Ozempic, we may be able to help you file a lawsuit and pursue compensation for your injuries.
Ozempic NAION Risks
NAION happens when blood flow to the optic nerve is reduced, depriving it of oxygen and causing damage. This condition, which is sometimes referred to as an “eye stroke,” typically leads to sudden and painless vision loss.
While researchers have identified an increased risk of NAION in patients taking semaglutide, the exact biological mechanism isn't yet fully understood. However, several theories have been proposed.
Ozempic NAION risks may be due to:
- Blood pressure and blood vessel effects: GLP-1 medications are known to lower blood pressure and influence how blood vessels regulate flow, which may contribute to reduced circulation in an already vulnerable optic nerve, according to the Asia-Pacific Journal of Ophthalmology.
- Nerve swelling restricted blood flow: Swelling within the optic nerve may close off small blood vessels supplying it, effectively starving the nerve of blood, according to Dr. Joseph Rizzo, the lead researcher behind the Mass Eye and Ear study.
- Rapid blood sugar changes: Semaglutide's rapid lowering of blood sugar may disrupt blood flow to the optic nerve, potentially triggering NAION in susceptible patients, per a case report published in Clinical Practice and Surgical Cases.
Patients with a naturally smaller optic disc (where the nerve connects to the eye) are already at higher risk for NAION, according to the American Optometric Association. This anatomical trait may make some patients more vulnerable to the drug's effects.
Blindness from NAION is often permanent. Our Ozempic vision loss lawyers may be able to help victims across the country seek justice for the harm they’ve suffered.
About NAION Ozempic Lawsuits
In December 2025, lawsuits involving GLP-1s and NAION were consolidated in a multidistrict litigation (MDL) in the U.S. District Court for the Eastern District of Pennsylvania.
When cases are centralized in an MDL, one judge oversees all pretrial matters like evidence gathering and expert testimony, rather than having each lawsuit handled separately in different courts. However, cases are still evaluated individually.
Find out more about NAION Ozempic lawsuits:
- There are currently 146 lawsuits pending in the Ozempic NAION MDL.
- The case is formally known as In Re: Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs) Non-Arteritic Anterior Ischemic Optic Neuropathy Products Liability Litigation or MDL No. 3163.
- The litigation covers NAION claims tied to multiple GLP-1 medications, including Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound.
- Novo Nordisk and Eli Lilly are both named as defendants in the case.
- The MDL is overseen by U.S. District Judge Karen S. Marston, who also presides over the related GLP-1 gastrointestinal injury MDL.
- Victims may be able to seek compensation for their medical bills, pain and suffering, and more.
If you or a loved one developed NAION after taking a GLP-1 medication, we can help you understand whether you qualify to join this litigation and pursue the compensation you may be owed.
Who Can File an Ozempic NAION Lawsuit?
To be eligible for an Ozempic NAION lawsuit, your lawyer must gather evidence showing you experienced sudden vision loss or blindness after taking Ozempic.
You may be able to file a NAION Ozempic lawsuit if you or a loved one:
- Used a GLP-1 medication like Ozempic, Wegovy, Rybelsus, Zepbound, Mounjaro, Saxenda, or Trulicity
- Suffered serious health issues like vision loss from non-arteritic anterior ischemic optic neuropathy (NAION) in one or both eyes
There’s only a limited amount of time to take legal action for NAION from Ozempic due to state laws known as statutes of limitations, so it’s important to reach out to an experienced attorney as soon as possible.
Call (800) 995-1212 now to see if you may be able to seek compensation from a NAION lawsuit. It costs nothing to speak with us.
Filing a NAION Ozempic Lawsuit
We understand the uncertainty and anxiety that may accompany an unexpected medical condition, especially one caused by your medication.
Our Ozempic NAION attorneys can handle every step of the legal process for you, so you can focus on your health and well-being.
If you have a case, your legal team can:
- Verify your eligibility to take legal action during a free case review
- Gather evidence like your medical records and testimony to build a strong case
- File your Ozempic lawsuit for blindness within any statutes of limitations or state deadlines
- Negotiate Ozempic NAION lawsuit settlements with the defendant(s)
- Present your case in a court trial if a settlement is unable to be reached
By filing a GLP-1 NAION lawsuit against the drug’s manufacturer, you may be able to secure compensation for medical bills, lost wages, pain and suffering, and more.
How to Choose the Right Ozempic NAION Lawyer
At Sokolove Law, we strive to make the legal process as accessible and stress-free as possible for our clients.
Our Ozempic NAION lawyers are dedicated to holding negligent pharmaceutical companies responsible for the harm they cause.
Learn how Sokolove Law stands out from the rest:
- Free Legal Consultations: We provide all potential clients with a free consultation to determine whether or not they may be eligible to file an Ozempic NAION lawsuit.
- Decades of Experience: For over 45 years, Sokolove Law has helped clients across the country pursue justice and hold the companies responsible for their injuries accountable.
- A History of Results: We’ve secured over $1.6 Billion for our clients affected by dangerous prescription drugs and medical devices.
- Offices & Attorneys Nationwide: As a national law firm, Sokolove Law can help with your case wherever you may be in the United States.
- No Financial Risk: There are no out-of-pocket or upfront costs to work with our Ozempic lawyers — we only get paid if you do.
Our Ozempic NAION attorneys have the resources and experience needed to hold negligent pharmaceutical companies responsible for the harm they’ve caused.
Get Help Filing an Ozempic Blindness Lawsuit
If you experienced vision loss after using Ozempic or another GLP-1 medication, we may be able to help you fight for compensation from an Ozempic blindness lawsuit.
Our attorneys have secured more than $1.6 Billion for families affected by dangerous drugs and medical devices.
There are no upfront costs or hourly fees to work with our Ozempic NAION lawyers. We only get paid if you do.
Call (800) 995-1212 now or fill out our contact form to get started with a free, no-obligation case review.
Semaglutide & Ozempic NAION Lawsuit FAQs
Who is the manufacturer of Ozempic?
Ozempic is manufactured by the Danish pharmaceutical company Novo Nordisk.
If you or a loved one experienced health issues after using Ozempic, you may be able to file a lawsuit against Novo Nordick.
Call Sokolove Law now at (800) 995-1212 to learn more.
Does Ozempic cause NAION?
Yes, using Ozempic may increase the risk of non-arteritic anterior ischemic optic neuropathy (NAION). Semaglutide users are more than 4 times as likely to develop NAION than patients taking other diabetes medications, and overweight or obese patients are over 7 times as likely to develop this condition, according to researchers at Massachusetts Eye and Ear.
To date, at least 146 semaglutide NAION lawsuits have been filed against drug companies for failing to warn users about this risk.
How common is NAION with Ozempic?
NAION is a rare condition, but there may be an increased risk for patients taking Ozempic. Among patients with type 2 diabetes, 8.9% of those prescribed semaglutide medications like Ozempic developed NAION over 36 months, compared to 1.8% of those on other diabetes medications, according to Massachusetts Eye and Ear.
Among patients who were overweight or had obesity, 6.7% of those prescribed semaglutide developed NAION over 36 months, compared to 0.8% of those on other weight-loss medications.
Anyone who experiences sudden vision changes while on Ozempic should seek medical attention as soon as possible.
Why is there a lawsuit against Ozempic?
Many families nationwide have filed semaglutide lawsuits against weight loss drugs like Ozempic, claiming Novo Nordisk failed to adequately warn patients about the side effects.
If you or a loved one used Ozempic and suffered serious health issues like vision loss, contact Sokolove Law now. You may be eligible for compensation from an Ozempic side effects lawsuit.
How much does it cost to file an Ozempic lawsuit?
At Sokolove Law, there are no upfront or hourly costs to file an Ozempic lawsuit.
Our Ozempic attorneys only get paid if your case results in compensation, so there's no financial risk to taking legal action.
What is the Ozempic NAION lawsuit?
The Ozempic NAION lawsuit involves claims that Ozempic and other GLP-1 drugs may increase the risk of a serious eye condition called non-arteritic anterior ischemic optic neuropathy (NAION), which occurs when blood flow to the optic nerve is disturbed or cut off.
This condition may result in sudden vision loss due to optic nerve damage, according to JAMA Ophthalmology. Those affected may be eligible for compensation from a GLP-1 NAION lawsuit.
What are common semaglutide and Ozempic side effects?
The use of Ozempic has been associated with health issues that users should be aware of before taking this medication.
Health issues linked to Ozempic and semaglutide include:
- Vision loss from NAION (non-arteritic anterior ischemic optic neuropathy)
- Bowel or intestinal obstructions
- Chronic vomiting
- Deep vein thrombosis (DVT)
- Esophageal injury
- Ileus (intestinal inability to contract and pass waste)
- Intraoperative pulmonary aspiration
- Malnutrition-related disorders
- Pancreatic cancer
- Stomach paralysis (gastroparesis)
Sadly, many of these side effects may be severe and require hospitalization or additional medical care.
If you became ill after using Ozempic, you don't have to face additional health complications alone. Contact Sokolove Law now for help understanding your options.
Is Ozempic approved for weight loss?
No. The FDA has not approved Ozempic for the sole purpose of weight loss at this time. This drug is currently approved to treat type-2 diabetes and reduce the risk of cardiovascular problems.
How does Ozempic work?
Ozempic mimics the glucagon-like peptide-1 receptor agonist (GLP-1 RAs) hormone in the body, which helps regulate blood sugar levels by increasing the secretion of insulin. This can also make users feel full.
In addition to Ozempic, semaglutide is also the active ingredient in Rybelsus tablets and Wegovy injections, which are also considered GLP-1 RAs.
However, semaglutide weight loss drugs like Ozempic may increase the risk of stomach paralysis and other health risks.
